Cargando…
Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection
We characterized the composition and structure of the vaginal microbiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were followed quarterly for 9 months after antibiotic treatment. At time of diagnosis, the vaginal microbiota was dominated by Lactobacillus...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530545/ https://www.ncbi.nlm.nih.gov/pubmed/31573603 http://dx.doi.org/10.1093/infdis/jiz499 |
_version_ | 1783589589674360832 |
---|---|
author | Tamarelle, Jeanne Ma, Bing Gajer, Pawel Humphrys, Mike S Terplan, Mishka Mark, Katrina S Thiébaut, Anne C M Forney, Larry J Brotman, Rebecca M Delarocque-Astagneau, Elisabeth Bavoil, Patrik M Ravel, Jacques |
author_facet | Tamarelle, Jeanne Ma, Bing Gajer, Pawel Humphrys, Mike S Terplan, Mishka Mark, Katrina S Thiébaut, Anne C M Forney, Larry J Brotman, Rebecca M Delarocque-Astagneau, Elisabeth Bavoil, Patrik M Ravel, Jacques |
author_sort | Tamarelle, Jeanne |
collection | PubMed |
description | We characterized the composition and structure of the vaginal microbiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were followed quarterly for 9 months after antibiotic treatment. At time of diagnosis, the vaginal microbiota was dominated by Lactobacillus iners or a diverse array of bacterial vaginosis–associated bacteria including Gardnerella vaginalis. Interestingly, L. iners–dominated communities were most common after azithromycin treatment (1 g monodose), consistent with the observed relative resistance of L. iners to azithromycin. Lactobacillus iners–dominated communities have been associated with increased risk of C. trachomatis infection, suggesting that the impact of antibiotic treatment on the vaginal microbiota could favor reinfections. These results provide support for the dual need to account for the potential perturbing effect(s) of antibiotic treatment on the vaginal microbiota, and to develop strategies to protect and restore optimal vaginal microbiota. |
format | Online Article Text |
id | pubmed-7530545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-75305452020-10-07 Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection Tamarelle, Jeanne Ma, Bing Gajer, Pawel Humphrys, Mike S Terplan, Mishka Mark, Katrina S Thiébaut, Anne C M Forney, Larry J Brotman, Rebecca M Delarocque-Astagneau, Elisabeth Bavoil, Patrik M Ravel, Jacques J Infect Dis Major Articles and Brief Reports We characterized the composition and structure of the vaginal microbiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were followed quarterly for 9 months after antibiotic treatment. At time of diagnosis, the vaginal microbiota was dominated by Lactobacillus iners or a diverse array of bacterial vaginosis–associated bacteria including Gardnerella vaginalis. Interestingly, L. iners–dominated communities were most common after azithromycin treatment (1 g monodose), consistent with the observed relative resistance of L. iners to azithromycin. Lactobacillus iners–dominated communities have been associated with increased risk of C. trachomatis infection, suggesting that the impact of antibiotic treatment on the vaginal microbiota could favor reinfections. These results provide support for the dual need to account for the potential perturbing effect(s) of antibiotic treatment on the vaginal microbiota, and to develop strategies to protect and restore optimal vaginal microbiota. Oxford University Press 2020-02-15 2019-10-01 /pmc/articles/PMC7530545/ /pubmed/31573603 http://dx.doi.org/10.1093/infdis/jiz499 Text en © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Articles and Brief Reports Tamarelle, Jeanne Ma, Bing Gajer, Pawel Humphrys, Mike S Terplan, Mishka Mark, Katrina S Thiébaut, Anne C M Forney, Larry J Brotman, Rebecca M Delarocque-Astagneau, Elisabeth Bavoil, Patrik M Ravel, Jacques Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection |
title | Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection |
title_full | Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection |
title_fullStr | Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection |
title_full_unstemmed | Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection |
title_short | Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection |
title_sort | nonoptimal vaginal microbiota after azithromycin treatment for chlamydia trachomatis infection |
topic | Major Articles and Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530545/ https://www.ncbi.nlm.nih.gov/pubmed/31573603 http://dx.doi.org/10.1093/infdis/jiz499 |
work_keys_str_mv | AT tamarellejeanne nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection AT mabing nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection AT gajerpawel nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection AT humphrysmikes nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection AT terplanmishka nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection AT markkatrinas nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection AT thiebautannecm nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection AT forneylarryj nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection AT brotmanrebeccam nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection AT delarocqueastagneauelisabeth nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection AT bavoilpatrikm nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection AT raveljacques nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection |